Quick answer: Quadax is a clearinghouse known for iQ pre-submission denial avoidance. Availity is a national payer-connectivity network with a free or low-cost hub and Advanced Real-Time Claim Status (276/277) for enrolled payers. Pick Quadax for edit-heavy submission. Pick Availity for enrolled-payer connectivity and EHR status pipes. Neither covers portal-only follow-up.
Inclusion criteria: Head-to-head on deployment model, EHR fit, payer coverage, and whether you must replace a clearinghouse or BPO.
Honest limitations: Substrate does not replace a clearinghouse, EHR, coder, or patient-billing platform. It automates post-submission AR. Claim status includes denial root-cause analysis (eligibility, records, medical necessity, wrong route), not just a 277 code or an 835 variance. Clinical edge cases still go to staff. Coding, CDI, and patient-facing billing are out of scope.
At a glance
Where Quadax wins
- iQ edits before the 837 is sent
- Denial avoidance as a clearinghouse service, not a free portal
- Buyers who already measure first-pass yield from edits
Where Availity wins
- 95%+ US payer connectivity narrative and a low-cost hub
- 276/277 into Epic for enrolled payers
- Eligibility, claims, and remits many groups already use daily
Also consider Substrate
Also consider Substrate when the gap is post-submission follow-up on the current PM: live in days, EDI and portal coverage across 3,500+ payers, PM writeback with a video audit trail, and denial root-cause analysis as part of claim status (eligibility, records, medical necessity, or wrong route) rather than a 277 code or an 835 variance alone. Substrate does not replace a clearinghouse, EHR, coder, or patient-billing platform. Keep Quadax or Availity for submission and enrolled 277s. Use an overlay when the next action depends on why the claim is unpaid, not whether the edit fired.